Tīmeklis2024. gada 28. jūl. · Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of Lys-27 in histone 3 (H3K27me3). EZH2 could also regulate gene expression in ways besides H3K27me3. Functions of EZH2 in cells … Tīmeklis肿瘤新型治疗靶点：EZH1/2. EZH2及其高度相关的同源基因EZH1被认为是表观遗传沉默因子，它们作为多梳抑制性复合体2 (PRC2)的核心成分，在细胞的生长和分化中起 …

Novel orally bioavailable EZH1/2 dual inhibitors with greater …

Tīmeklis2024. gada 13. nov. · Herein, we introduce a novel EZH1/2 dual inhibitor, HM97594, which simultaneously inhibits the methyltransferase activity of wild-type EZH1 as well as wild-type and GOF mutant EZH2 at nanomolar concentrations. HM97594 potently repressed trimethylation of H3K27 in lymphoma and myeloma cell lines. http://m.biospectator.com/view/news_view.php?varAtcId=16073 peacock joinery cambridge

DOI Doc URL - HUSCAP

Tīmeklis2011. gada 27. jūl. · Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. ... Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK … Tīmeklis2024. gada 15. dec. · UNC1999 is an orally bioavailable EZH1/2 inhibitor with a 10-fold selective toward EZH2 (compared with >150-fold with GSK126). In MLL-rearranged leukemia, it suppresses tumor growth . Valemetostat Tosylate (DS-3201b) is another EZH1/2 dual inhibitor that has demonstrated synthetic lethality in malignancies … TīmeklisUNC1999 is highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM, and non-competitive with the peptide substrate. UNC1999 has K i values of 4,700 nM, 65 nM, 300 nM, and 1,500 nM for sigma1, sigma2, histamine H 3 , and NET, respectively. peacock johnson